Skip to Content

Alibaba Health Information Technology Ltd ALBHF

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Alibaba Health Information Technology Ltd is an investment holding company. The company is primarily engaged in pharmaceutical direct business, operation of pharmaceutical e-commerce platform, consumer healthcare services platform, provision of tracking and digital health business, and internet healthcare business. Through the pharmaceutical direct business, the group provides customers with a wide range of products with strict quality control, including prescription drugs, over-the-counter (OTC) drugs, health supplements, medical devices, contact lenses, and skincare. It generates maximum revenue from Pharmaceutical direct business. Geographically, it derives a majority of revenue from Mainland China.

Contact
Hong Tai Dong Jie, 17th to 19th Floors, Building B, Greenland Center
Beijing, 100102, Bermuda
T +86 1058259000
Sector Healthcare
Industry Pharmaceutical Retailers
Most Recent Earnings
Fiscal Year End Mar 31, 2021
Stock Type
Employees 990